Trexquant Investment LP Buys Shares of 44,973 Humana Inc. $HUM

Key Points

• Trexquant Investment LP has invested approximately $11.90 million in Humana Inc., acquiring 44,973 shares during the first quarter.
• Humana's recent quarterly earnings report revealed an EPS of $6.27, falling short of the predicted $6.32, while revenue increased by 9.6% year-over-year.
• Wall Street analysts have issued a consensus rating of "Hold" for Humana, with a target price ranging from $260.00 to $297.00 by various firms.

Trexquant Investment LP acquired a new position in shares of Humana Inc. (NYSE:HUM - Free Report) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 44,973 shares of the insurance provider's stock, valued at approximately $11,900,000.

Other large investors have also added to or reduced their stakes in the company. Cary Street Partners Investment Advisory LLC raised its stake in Humana by 63.9% in the 1st quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider's stock valued at $31,000 after acquiring an additional 46 shares during the period. Riverview Trust Co bought a new stake in Humana in the 1st quarter valued at $34,000. Garde Capital Inc. bought a new stake in Humana in the 1st quarter valued at $36,000. Zions Bancorporation National Association UT bought a new stake in Humana in the 1st quarter valued at $37,000. Finally, Whipplewood Advisors LLC raised its stake in Humana by 639.1% in the 1st quarter. Whipplewood Advisors LLC now owns 170 shares of the insurance provider's stock valued at $45,000 after acquiring an additional 147 shares during the period. Institutional investors own 92.38% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts have commented on the company. Royal Bank Of Canada upped their price objective on Humana from $283.00 to $322.00 and gave the company an "outperform" rating in a report on Thursday, August 21st. Wells Fargo & Company decreased their price objective on Humana from $348.00 to $344.00 and set an "overweight" rating on the stock in a report on Thursday, August 14th. Bank of America decreased their price objective on Humana from $320.00 to $260.00 and set a "neutral" rating on the stock in a report on Tuesday, June 17th. Piper Sandler decreased their price objective on Humana from $288.00 to $272.00 and set a "neutral" rating on the stock in a report on Thursday, July 31st. Finally, Morgan Stanley decreased their price objective on Humana from $290.00 to $277.00 and set an "equal weight" rating on the stock in a report on Thursday, July 31st. Seven investment analysts have rated the stock with a Buy rating and sixteen have given a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $283.29.

Humana Price Performance

Shares of HUM traded up $6.01 during trading hours on Friday, hitting $303.90. 1,099,760 shares of the company were exchanged, compared to its average volume of 1,366,524. The company has a market cap of $36.55 billion, a price-to-earnings ratio of 23.32, a P/E/G ratio of 1.79 and a beta of 0.44. Humana Inc. has a fifty-two week low of $206.87 and a fifty-two week high of $382.72. The company has a quick ratio of 1.95, a current ratio of 1.95 and a debt-to-equity ratio of 0.69. The firm's fifty day moving average is $254.43 and its 200 day moving average is $254.59.

Humana (NYSE:HUM - Get Free Report) last released its earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $6.32 by ($0.05). The company had revenue of $32.39 billion for the quarter, compared to analyst estimates of $31.85 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.The business's revenue for the quarter was up 9.6% compared to the same quarter last year. During the same period last year, the company posted $6.96 earnings per share. Humana has set its FY 2025 guidance at 17.000- EPS. On average, equities analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be paid a $0.885 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $3.54 annualized dividend and a yield of 1.2%. Humana's dividend payout ratio (DPR) is 27.17%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.